These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 369645)

  • 1. A clinical trial of endolymphatic therapy in malignant melanoma: interim report of the progress of the Medical Research Council trial.
    Br J Surg; 1979 Jan; 66(1):9-13. PubMed ID: 369645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endolymphatic isotope and BCG in the management of malignant melanoma.
    Edwards JM; Pheils PJ
    Aust N Z J Surg; 1978 Feb; 48(1):40-8. PubMed ID: 276347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymphographically detectable long-term changes caused by endolymphatic radionuclide therapy (ELRT) in the infradiaphragmatic lymph system].
    Müller RP; Peters PE
    Strahlentherapie; 1985 Apr; 161(4):239-43. PubMed ID: 2986321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endolymphatic radionuclide therapy of the malignant melanoma (author's transl)].
    Makoski HB; Scherer E; Magnus L; Verbeek W
    Strahlentherapie; 1978 Mar; 154(3):169-73. PubMed ID: 635942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical results of endolymphatic radionuclide therapy in the treatment of malignant melanoma].
    Makoski HB; Magnus L; Heissen E; Kolpatzik H; Drepper H
    Strahlentherapie; 1974 Jul; 148(1):1-15. PubMed ID: 4612879
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endolymphatic radiotherapy in malignant melanoma of the lower extremities].
    Kalkoff P; Baumeister L; Gehring D
    Arch Dermatol Forsch; 1972; 244():250-4. PubMed ID: 4648700
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lymphography and endolymphatic chemotherapy in malignant tumours (author's transl)].
    Miroljubov NN; Laletin VG
    Radiol Diagn (Berl); 1976 Dec; 17(6):827-32. PubMed ID: 190639
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tabular and case demonstrations of 100 malignant melanomas treated by endolymphatic therapy].
    Makoski HB; Scherer E
    Med Welt; 1974 Jun; 25(23):1042-4. PubMed ID: 4605981
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
    Henderson MA; Burmeister BH; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2015 Sep; 16(9):1049-1060. PubMed ID: 26206146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Examination technic and monitoring of patients in endolymphatic radionuclide therapy].
    Peters PE
    Med Welt; 1974 Jun; 25(23):1031-5. PubMed ID: 4409524
    [No Abstract]   [Full Text] [Related]  

  • 11. [Radiation dose to the lung following endolymphatic radionuclide therapy of melanoma of the lower limbs].
    Müller RP; Peters PE
    Strahlentherapie; 1985 Jan; 161(1):23-9. PubMed ID: 2982221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of lymphographic course controls following endolymphatic radionuclide therapy].
    Wolf G
    Med Welt; 1974 Jun; 25(23):1050-4. PubMed ID: 4410764
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
    Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reliability of the diagnostic results obtained with confined quantities of the contrast medium in endolymphatic radionuclide therapy (ELRT) of the inferior limbs (author's transl)].
    Müller RP; Schnepper E; Peters PE; Fladerer W
    Strahlentherapie; 1980 Aug; 156(8):538-41. PubMed ID: 7414647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endolymphatic radionuclide adjuvant therapy of melanoma and its side effects on the cellular immune system].
    Richter G; Heidenbluth I; Heidelbach U
    Dermatol Monatsschr; 1982 Dec; 168(12):797-806. PubMed ID: 7169101
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathomorphosis of metastatic malignant melanoma of the skin as effected by preoperative endolymphatic polychemotherapy].
    Naleskina LA; Tolstopiatov BA; Korovin SI
    Klin Khir (1962); 1993; (5):27-30. PubMed ID: 7933857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study of a new method of endolymphatic antibiotic administration and a trial of its clinical use].
    Shcherbakova EG; Vyrenkov IuE; Panchenkov RT; Iarema IV; Myl'nikov AV
    Antibiotiki; 1980 May; 25(5):375-81. PubMed ID: 6992708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of adjuvant therapy in patients with metastasis of melanoma to regional lymph nodes].
    Korovin SI
    Klin Khir; 1998; (2):22-3. PubMed ID: 9615073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follow-up studies on malignant melanomas after endolymphatic radionuclide therapy].
    Gehring D; Baumeister L
    Med Welt; 1974 Jun; 25(23):1045-7. PubMed ID: 4409591
    [No Abstract]   [Full Text] [Related]  

  • 20. [Endolymphatic therapy in the treatment of primary delimited melanoblastoma of the skin].
    Korovin SI
    Klin Khir; 1998; (1):39-40. PubMed ID: 9615056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.